Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxart, Inc

0.4775
+0.00751.60%
Volume:120.18K
Turnover:58.03K
Market Cap:108.62M
PE:-1.19
High:0.4900
Open:0.4900
Low:0.4731
Close:0.4700
Loading ...

BRIEF-Vaxart Completes Enrollment Of Sentinel Cohort In Phase 2B Study

Reuters
·
03 Dec 2024

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2B Study Evaluating Its Covid-19 Oral Pill Vaccine Candidate

THOMSON REUTERS
·
03 Dec 2024

Vaxart reports inducement grants under Nasdaq listing rule

TIPRANKS
·
19 Nov 2024

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
19 Nov 2024

Vaxart Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
16 Nov 2024

Vaxart (VXRT) Receives a Buy from Oppenheimer

TIPRANKS
·
14 Nov 2024

Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and ...

GuruFocus.com
·
14 Nov 2024

Vaxart Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
14 Nov 2024

Vaxart Q3 EPS $(0.06) Beats $(0.10) Estimate, Sales $4.93M Beat $850.00K Estimate

Benzinga
·
14 Nov 2024

Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results

THOMSON REUTERS
·
14 Nov 2024

Vaxart Q3 Pretax Profit USD -14.062 Million

THOMSON REUTERS
·
14 Nov 2024

Here are the major earnings after the close today

seekingalpha
·
13 Nov 2024

Vaxart Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Vaxart Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13

GlobeNewswire
·
07 Nov 2024